.-The purpose of the present study was to determine whether myocardial oxygen consumption (MOON) differs when the heart is arrested by hyperkalemic arresting solution (ASK) or by hypocalcemic arresting solution (A&,) when coronary flow is maintained constant. Mvoz was measured in 12 isolated, Langendorff-perfused rat hearts alternately perfused with ASK (20 mM K+ and 1.5 mM Ca2+) and A&, (5 mM K+ and 0.08 mM Ca"+). Six of the hearts were perfused with ASK for 10 min, A&, for 5 min, ASK for a second 5 min, and finally A& for 5 min; ASca and ASK were opposite in this sequence for the other six hearts. Measurements of MAO, during A& and ASca arrest, taken at the end of each perfusion period, were analyzed to distinguish the independent influences of time and perfusate composition on Mvo2 in the arrested hearts (analysis of covariance). Consistent with previous findings, Mvo2 decreased with time after the onset of cardiac arrest with both solutions. The average per minute fall was 0.0003 ml 02*min-l l g-l (P < 0.01).
taken at the end of each perfusion period, were analyzed to distinguish the independent influences of time and perfusate composition on Mvo2 in the arrested hearts (analysis of covariance). Consistent with previous findings, Mvo2 decreased with time after the onset of cardiac arrest with both solutions. The average per minute fall was 0.0003 ml 02*min-l l g-l (P < 0.01).
However, at any given time after arrest, MVo2 averaged 0.004 ml. min. g-l less during AS ca arrest than during ASK arrest (P < O.Ol), which amounted to a 15% reduction in MVo2. To test whether the increased Mvo2 during hyperkalemic arrest was dependent on calcium in the perfusion medium, a third series of six hearts was studied in which Mvo2 values measured during ASca and ASK arrest were compared with those measured during arrest by hyperkalemic-hypocalcemic solution (ASk,ca: 20 mM K+, 0.08 mM Ca2+). Mv02 measured during ASk,ca arrest was not different from that during ASca arrest (P > 0.2) and was less than Mvo2 measured during ASK arrest (P < 0.05). Thus MVo2 of the arrested heart measured at constant coronary flow is greater during hyperkalemic arrest than during hypocalcemic arrest; furthermore, the increased MVo2 during hyperkalemic arrest is calcium dependent.
calcium; cardiac metabolism; cardioplegia; coronary resistance THE BASAL METABOLIC ENERGY requirementofmyocardial tissue is assessed by measuring myocardial oxygen consumption ( MVO& after cessation of contractile activity. Because basal MVoz (MVO& accounts for a significant proportion of total MVO~, there has been significant interest in understanding the determinants of this entity.
A variety of strategies have been used to arrest the heart for the purpose of measuring MVO~, B (3, [5] [6] [7] [8] [9] 11, 15) . The most commonly investigated strategies have been 1) increasing perfusate potassium concentration and 2) decreasing perfusate calcium concentration. However, there is considerable discrepancy in the literature regarding which of these provides a lower value for MVoz and thus a more accurate estimate of MTjo,B. Several studies have shown that arresting the heart 'by hyperkalemic solutions yields a lower MVO~ B (5, 11). Others show that hypocalcemic arrest has a loier MVo2 B (8,9). , Another study indicates that there is no difference in M'i70~ B be ,
At least tween these two methods of arresting the heart two factors have contributed to this discrepancy. First, there is a strong dependence of M%702B on coronary flow (5, 6). Coronary vascular resistance is significantly lower with hypocalcemic than with hyperkalemic perfusion, and all of the aforementioned studies comparing MV 02,~ with these two methods of arresting the heart have been done under conditions of constant perfusion pressure. Consequently, coronary flow rates have been consistently greater (as much as threefold higher) during low calcium perfusion than during high potassium perfusion. Thus, differences in Mi702 B noted between the two perfusates may have been caused predominantly by changes in flow and therefore do not reflect differences due to perfusate compositions.
A second limitation of previous studies is that comparisons of MVO 2,~ using the two strategies of cardiac arrest have always been made in separate groups of hearts. This would make detection of small differences in MVo2B difficult because of inherent interheart variability.
MVo2
Hyperkalemic arrest leads to calcium loading of myocytes (4, 10, 13), which could enhance their energy requirements by several mechanisms. Thus there is reason to expect that MAO 2,~ would be greater during hyperkalemic than hypocalcemic arrest. The present study was undertaken to determine whether Mvo2 differs when the heart is arrested by perfusion with solutions containing either high KC1 concentrations or low calcium concentrations under conditions of constant coronary flow. Comparisons of MVo2 B . determined during arrest by the two solutions were made in individual hearts, with the experiments designed and analyzed to account for the fact that MVo2 B decreases with time after isolated hearts , are arrested (5, 8, 11, 15 Hl143 heparinized (1,000 U ip) and then was heavily anesthetized with pentobarbital sodium (140 mg ip). Bilateral sternotomy was performed, and the inferior and superior vena cavae were ligated near their insertions into the right atrium. The heart was excised and immediately submerged into oxygenated, warmed perfusate (composition provided below). The severed end of the aorta was fed over an 18gauge needle that was connected to a Langendorff perfusion system. Perfusate flow was adjusted to provide a perfusion pressure of 80 mmHg and then flow was kept constant throughout the experiment. Coronary flow averaged 9.59 t 1.25 ml l min-l l g wet wt-l in all hearts studied.
A thin piece of Tygon tubing with a fenestrated tip was advanced into the right ventricle via the main pulmonary artery and held in place by a suture placed at the base of the pulmonary artery. This tube served to collect all of the coronary sinus and right ventricular Thebesian perfusate flow.
The left atrium was opened with care to ensure that the interatrial septum was not damaged. A balloon, made of polyvinyl chloride and attached to the end of an 8 cm length of stiff polyethylene tubing, was inserted into the left ventricle. This was held in place by a purse-string suture around the remaining left atria1 tissue. The balloon and tubing were filled with water and connected to a Statham strain gauge for measurement of ventricular pressure. Balloon volume was set to provide an enddiastolic pressure of -4 mmHg (range 3-5) and kept constant throughout the entire experiment.
The perfusion system consisted of three separate storage vats for perfusate solutions: a Masterflex adjustable speed rotary pump (model 7523-lo), a condenser, and a bubble trap. The storage vats and condenser were warmed by a VWR Constant Temperature Circulator (model 1135) set to heat the solutions to 37°C.
For each experiment, three different perfusates were prepared. The control solution was composed of (in mM) 140 NaCl, 5 KCl, 1.23 MgCl,, 6 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 15 glucose, and 1.5 CaCIZ. Lidocaine (0.5 pg/ml) was also added. One of the arrest solutions had 20 mM KC1 with NaCl decreased to 125 mM (ASK) so as to maintain osmotic pressure. The second arrest solution had the control KC1 concentration, but CaCIZ decreased to 0.08 mM (AS&. In preliminary experiments we also explored a third arrest solution, which contained (in mM) 20 KCl, 125 NaC1, and 0.08 CaCIZ (ASK ca). Each solution was warmed to 37°C; the pH was adjusted to 7.40. Each solution was equilibrated with 100% 02 for 20 min before use. Perfusate was not recirculated.
Oxygen consumption measurement. Oxygen consumption was calculated by multiplying the coronary arterial flow by the difference in oxygen content between arterial and venous perfusates. To estimate oxygen contents, we measured oxygen tension using a commercially available platinum oxygen electrode system (Instech, Plymouth Meeting, PA) which allowed for continuous measurements. Sodium dithionate (a compound that extracts oxygen from solution) was used to zero the electrode at the start of each experiment. The gain of the electrode system was calibrated in each experiment by measuring the arterial oxygen tension. Values for oxygen tensions were read off of a digital meter, which is part of the electrode system. A tubing system was devised to divert either all of the venous or all of the arterial perfusate flow through the electrode system for on-line sampling.
Protocol. After isolation and attachment to the Langendorff perfusion system, the hearts were allowed to stabilize for 30 min while perfused with the control solution and paced at a rate of 180 beats/min. During this time, we monitored isovolumic left ventricular pressure (LVP) and venous oxygen tension. This stabilization period was extended, when necessary, until both these signals were stable (i.e., no detectable change) for at least 1 min. The comparison between MOON measured in the same heart arrested by ASK and ASca is complicated by the fact that MVoz decreases with time after arrest in isolated crystalloid perfused hearts. We therefore designed a protocol in which we made repeated measures of MTjo2 with the hearts alternately perfused with these two solutions.
In one group of six hearts, perfusate was switched to ASK after the stabilization period, at which point the hearts became asystolic. Perfusion was continued for 10 min, by which time venous oxygen tension was nearly constant and recordings of LVP, coronary perfusion pressure (CPP) and venous oxygen tension were made. Then, at 5-min intervals, perfusate was switched back and forth between A& and ASK; measurements of LVP, CPP, and venous oxygen tension were made at the end of each of these periods. Perfusates were switched repeatedly so that these measurements were made at two different times with each perfusate. Finally, perfusate was returned to the control solution. The hearts beat spontaneously within 30 s of perfusion with control solution, at which point pacing was started at 180 beats/min; LVP, CPP, and venous oxygen reached a stable level between 5 and 10 min later. In six other hearts, the same basic sequence was executed except that the order of ASo, and ASK was reversed. Stability of the oxygen electrode system was tested by comparing its reading of the arterial perfusate oxygen tension during the initial and final perfusion periods with control solutions. The variation in electrode determination of the oxygen tension in the arterial solution between the start and the end of the experiment was 1.7 t 1.8%.
In preliminary studies (n = 6 hearts), we compared Mvo2 recorded in hearts alternately perfused with A& ASK, and ASkca. Measurements were made at only one time with each arresting solution, and the order in which tests were performed was randomized from one heart to the next. As described below, we found no significant change in MVO~ on switching between ASca and ASKca perfusates.
Therefore, we did not perform a separate series of studies using the rigorous protocol outlined above to compare AS k,ca with ASK or with AScam
Other control studies were performed to test whether the results were the same if 1) young adult hearts were used instead of retired male breeders (from 200 g rats, n = 2); 2) Krebs-Henseleit buffer was used instead of HEPES buffer (n=2); and 3) lidocaine was deleted from the perfusate (n = 2). In all cases, the results were the same as those obtained in the 12 hearts comprising the main study and will not be discussed further. Statistical analysis. Analysis of covariance was used to determine whether there was a statistically significant difference in MOON when the hearts were arrested by ASK or A&,. In setting up the statistical model, perfusate was coded as a dummy variable and time was entered as the covariate. Data from both groups of hearts were pooled in this analysis. All calculations were performed using SY STAT, a commercially available statistical package. perfusion A similar pressure analysis was performed to test for and intraventricular pressure differences between the two perfusates.
End-diastolic pressures, peak systolic pressures, coronary perfusion pressures, and MVO, measured under steady-state conditions before and after the periods of arrest were compared by paired t tests.
RESULTS
Typical recordings of LVP obtained on switching between various perfusates at constant coronary flow rates are shown in Fig. 1 . The hearts were paced at a rate of 180 beats/min during the control period; the pacer was turned off within the first 15 s of cardiac arrest. When the control perfusate was than .ged to the hyperkalemic arresting solution (ASK), there was a transient increase in developed pressure, which was followed by a rather abrupt decrease and then cessation of press ure generation (Fig. 1A ) . After arrest, LVP increased to a stable plateau level. Mvo2 increased transiently with the rise in deve loped pressure and then fell precipitously once contractions stopped. CPP decreased initially but then increased gradually and usually reached a level that was approximately the same as that during the control period.
After 10 min of ASK perfusion, perfusate was switched to the hypocalcemic arresting solution (A&,) ( Fig. 1B ; data from same heart as in Fig. 1A ). Within 45 s, spontaneous contractions were observed. Developed pressure was large in the first contraction but then decayed in a beat-dependent manner. LVP in the arrested state was not significantly different during ASK and A&, perfusion. In eight of the twelve hearts studied, there were no detectable contractions on the pressure tracing during A&, perfusion; however, in four of the hearts, the steadystate developed pressure was between 1 and 2 mmHg with a spontaneous rate between 10 and 25 beats/min (though not easily detectable, such contractions are present in Fig. 1B) . CPP usually decreased during A& perfusion compared with during ASK perfusion, indicating decreased coronary artery resistance (see below for further details). MOON usually decreased within -20 s of switching from ASk to ASca (before the onset of spontaneous contractions) and did not increase appreciably even after the brief period of contractions.
The recordings in Fig. 1 , C and D, are from a second heart, which was arrested initially by ASca. On switching from control to A&, perfusion, developed pressure declined, to 0 mmHg in this case, while diastolic pressure increased slightly. As was true in ASK, the LVP was greater during the arrest period than was the end-diastolic pressure before the arrest of the heart. MVO~ decreased monotonically after contractions ceased. CPP decreased immediately after switching from control to A&, and increased gradually with time.
About 30 s after switching from A& to Ask, contractile activity was noted. In contrast to what was observed when ASK was changed to A&,, the initial contractions were very weak; they increased gradually in strength and, finally, ceased abruptly. During this same time, MVO~ increased significantly while contractions were present and subsequently decreased to a level that was still greater than the MAO, level that existed during A& perfusion. CPP always increased after the switch from ASo, to Ask.
Measurements of basal MvoZ obtained from the first series of six hearts that were arrested initially by ASK are summarized in Fig. 2 , top. There was a trend for MAO, to decrease each time the perfusate was switched from ASK to A& and for MOON to increase when perfusate was switched from A& to ASK. There was also a tendency for MvoB to decrease with time after the hearts were arrested, which superimposed on the effects of the two perfusates. Results from the second series of six hearts, which were arrested initially by A&, are shown in Fig. 2 , middle. The same trends noted for the first series of hearts with regard to the effect of arresting solution and time on MVO, were also present in this series. To test for a time-independent, statistically significant difference in Mvo2 between the two arresting solutions, data from both series of hearts were pooled (Fig. 2, bottom) and analysis of covariance was employed to test for differences between the relations. MVO~ decreased with time in both arresting solutions at an average rate of 0.0003 ml 0,. min-20g-1. This rate was not statistically different between ASK and ASc, arrest. The elevation of the regression to the ASK data was statistically greater than that of the regression to the A&, data (P < 0.01). The magnitude of the increase in Mvoa with ASK arrest averaged 0.004 ml OZ. min. g-l over that measured with A&, arrest between times 10 and 25 min after the onset of arrest. This difference translates into an -15% decrease in MVO 2,~ when cardiac arrest was established by A&,.
As noted above, ventricular pressure during the period of cardiac arrest was greater than the end-diastolic pressure that existed before initiation of arrest by either ASK or ASo,. The effect of perfusate composition on LVP under arrested conditions is summarized in Fig. 3, top, for the two groups of hearts separately. As is shown, there is a slight trend for LVP to be lower when perfusion is with A&, and a slight trend for LVP to increase with time. However, neither of these trends was statistically significant. Of note, venous oxygen tension during cardiac arrest averaged 463 t 64 mmHg, so it is unlikely that these hearts were oxygen limited during the arrest period.
Coronary perfusion pressure also varied between ASK and A&, perfusion, as summarized in Fig. 3, bottom. Unlike the other characteristics analyzed, the CPP response was dependent on the composition of the initial arrest solution. In those hearts initially perfused with ASk (circles), CPP was consistently greater during ASK than during ASo, perfusion. There was no statistically significant time dependence of CPP in this series of hearts. In those hearts perfused initially with A&, (squares), however, CPP increased each time perfusate was switched from A&, to ASK but did not fall when perfusion was switched from ASK to A&, (i.e., between 15 and 20 min). Rather, in this latter series, there was a considerable time dependence of CPP that overshadowed the effect of perfusate composition.
As mentioned in METHOD?, six other experiments were performed to compare MVO~ during ASK, A&,, and ASk,ca arrests. In this group of hearts, each arresting solution was tested only once and the order in which they were tested was varied randomly. On switching Fig. 4 ; statistical comparisons between the three groups were accomplished by paired t tests with the P values adjusted for multiple comparisons (i.e., Bonferroni correction). MV& averaged 0.022 ml 020min-10 g-l during ASk,ca arrest and 0.030 ml 02.min-10 g-l during ASK arrest (P < 0.05). MVo2 measured during ASca arrest was 0.022 ml OZ. min-' . g'-l, which was significantly less than that measured during ASK arrest but the same as that measured during ASK ca arrest.
Pre-versus pdstarrest ventricular properties. Ventricular properties determined under beating conditions before and after the 25min period of arrest in the 12 hearts comprising the main protocol were compared using paired t tests, and the results are summarized in Table  1 . The results are the same for both groups of hearts (i.e., those initially arrested with ASK and those initially arrested with ASca), so all data are pooled and are not distinguished from each other. Peak LVP averaged 93.8 mmHg before initiation of arrest (control) and returned to 90.4 mmHg (NS from control) after perfusion was restored to the control solution (recontrol).
There was a statistically insignificant trend for end-diastolic pressure to be greater at the end of the experimental period. Mean CPP increased significantly, from 81.7 to 104.4 mmHg (P < O.OOl), indicating a considerable increase in coronary vascular resistance.
Finally, Mvoq decreased significantly from 0.105 to 0.094 ml 02*min-10 g-l (P C 0.001). This decrease in MvoP of 0.011 ml OZ. min-' l 8-l was greater than the average decrease of 0.006 ml Oao min-' l 8-l in MAO, observed in basal Mvo2 over the 25 min arrest period (see Fig. 2 , bottom).
DISCUSSION
The primary finding of the present study is that MVO~ is -15% less, on average, when the crystalloid perfused rat heart is arrested with a hypocalcemic solution (ASca) than when it is arrested with a hyperkalemic solution (ASK) under conditions of constant coronary flow. The increased MVO~ is not observed during hyperkalemic arrest if the arresting solution is also made hypocalcemic (AsK,Ca) l Results of previous studies have conflicted with regard to whether MVo2 is less when the heart is arrested by solutions containing a low calcium concentration or a high potassium concentration. This may stem partly from the fact that coronary vascular resistance is lower in hearts arrested by ASca than in those arrested by ASK, and most previous studies were performed at a constant coronary perfusion pressure. As a result, coronary flows were considerably higher during ASca arrest than during ASK arrest. Results of two studies have shown that MVO~ is influenced significantly *by coronary flow. Hauge and Oye (6) reported that MVO~ measured in isolated rat hearts arrested by hyperkalemic solutions increased when coronary flow was increased after coronary vasodilation with adenosine at a constant coronary perfusion pressure. In contrast, when flow was maintained constant but coronary perfusion pressure was allowed to fall after adenosine infusion, MVO~ did not change. *Thus, coronary flow, not pressure, influences basal MVO~ in the arrested rat heart. Consistent with these findings, Gibbs and Kotsanas (5) demonstrated in rabbit hearts perfused at 27°C that coronary flow had a profound influence on Mvoz in the arrested heart. Results of one study (l5), however, failed to show any change in basal MVO~ with changes in coronary flow. The reason for this discrepancy is not clear. Nevertheless, in view of the likely dependence of basal MAO, on coronary flow, it would be difficult to reproduce the results of t-he present study if comparisons are made between MVO~ values obtained from separate groups of hearts arrested by only one of the arresting solutions, as was done in previous studies, because the absolute differences are relatively small and it would be difficult to ensure that coronary flow rates were precisely equivalent in each heart.
A possible mechanism underlying the differences in MVo2 observed between ASK and ASca perfusion is suggested by the differences observed in the LVP tracings on switching between the various perfusates. When perfusate was switched from control to AScay contractility declined monotonically during which time it is assumed that the myocytes become depleted of intracellular calcium (Fig. 1C) . In contrast, the large rise in contractile performance observed on switching from normal perfusion to ASK is consistent with a large rise in intracellular calcium (Fig. IA) . Cellular calcium loading is also suggested by the LVP tracings obtained on switching from ASK to showing the very large initial contraction,
